Bausch + Lomb Corp (BLCO)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 24.46 |
|---|---|
| 52-week range | 20.25 – 25.70 |
| Return, 1 month / 3 months | +1.4% / +8.8% |
| Return, 1 year / 3 years | +10.8% / +9.2% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 32.0% |
| Worst drawdown (1 year) | -18.9% |
| Average daily value traded | 0.04M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bausch + Lomb is an eye health company based in Canada that makes contact lenses, lens care solutions and eye drops, along with surgical products for eye procedures such as intraocular lenses and ophthalmic medicines. Its customers include eye care professionals, hospitals and clinics, and consumers who buy vision care products. The company also offers products for dry eye, allergies and other eye conditions, serving markets around the world through its vision care and surgical divisions.
On this site Bausch + Lomb Corp appears as a stock on the Toronto Exchange (Canada), code BLCO, with prices in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bausch + Lomb Corp (BLCO) trades on the Toronto Exchange in Canada. It last closed at CAD 24.46 on 23 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 287 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.8% and over the last three months it rose 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 6.1% | ||
| From 52-week high | -3.7% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.8% | ||
| 6-month return | 13.6% | ||
| 12-month return, skipping the last month | 9.3% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.9% | ||
| Liquidity | 18 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.04M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.8% |
|---|---|
| 1 month | +1.4% |
| 3 months | +8.8% |
| 6 months | +13.6% |
| 1 year | +10.8% |
| 3 years | +9.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 24.03 / 23.05 |
|---|---|
| Golden / death cross (60 days) | Golden, 46 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.52 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.